Search

QBRI Insights: Influence of Host and Viral Genome Variation on COVID-19 24 Jun 2020 Home The entire human genome is made up of 6.4 billion nucleotides, which are individual positions in the human DNA denoted by the letters ‘A’,’T’,’C’ and ‘G’. In comparison, the SARS-CoV-2 genome is much smaller, with only about 29,000 nucleotides. This week, QBRI experts discuss how variations in the human host and viral genome sequence may determine the risk and severity of COVID-19. Mutation of SARS-CoV-2  …

QBRI Insights: COVID-19 in Pediatric Cases and Diabetic Patient Management 07 Jul 2020 Home Since the outbreak of the COVID-19 pandemic earlier this year, researchers and medical practitioners have been intensively studying the etiology of this disease and discerning its risk is population sub-groups. This week, QBRI experts discuss what is known about COVID-19 in children and how the disease can be managed in high-risk diabetic patients. COVID-19 in Children The COVID-19 pandemic has not been …

QBRI Insights: Severe COVID-19 Immunopathology and Computed Tomography-Based Diagnosis 21 Jul 2020 Home While the majority of COVID-19 patients experience mild symptoms, about 20% of cases develop severe pneumonia and respiratory failure. This week, QBRI experts discuss the hyper-activation of the immune defense system and detection of pneumonia by Computed Tomography (CT) in severe COVID-19 cases.  The immune landscape in severe COVID-19 The major elements of the human immune system (Figure 1) …

… incidence of cirrhosis, a late stage of liver damage, in the general population varies between 4.5% and 9.5% (4).  In Qatar, according to a 2017 Global Burden of Disease report, liver cirrhosis was the seventh leading cause of death (5). … incidence of cirrhosis, a late stage of liver damage, in the general population varies between 4.5% and 9.5% (4).  In Qatar, according to a 2017 Global Burden of Disease report, liver cirrhosis was the seventh leading cause of death (5). …

The Role of Convalescent Plasma Therapy in Treating COVID-19 Patients 25 Aug 2020 Home Dr. Nour Majbour, Research Associate at QBRI’s Neurological Disorders Research Center, and Dr. Omar El-Agnaf, Executive Director of QBRI, discuss how convalescent plasma can aid recovery from COVID-19 Convalescent plasma was once the traditional therapeutic approach for preventing and treating bacterial and viral infections, but the development of antibiotics and vaccines saw its role greatly diminishing. …

… of acceptable quality water for sustaining livelihoods, human well-being, and socio-economic development”. The case of Qatar, similar to other Gulf countries, is emblematic of this definition. Scarce renewable water resources, paired with … 26 Jun 2022 Read more QEERI Experts Discuss Carbon Emissions at Science Majlis 10 Apr 2022 Read more World Water Day: Qatar’s Groundwater Challenges 22 Mar 2022 Read more Flagship ICSEWEN21 Conference Sees High-Level Stakeholders 22 Nov 2021 Read more Tackling Corrosion Challenges: A Decade of Qatar Environment and Energy Research Institute 26 Sep 2021 Read more Scientific Research Raises Level of Urban Air …

… QBRI Insights: Living with the Coronavirus 09 Sep 2020 Home Both globally and in Qatar, most activities and businesses are resuming in phases, including travel and schools. While the COVID-19 pandemic … Both globally and in Qatar, most activities and businesses are resuming in phases, including travel and schools. While the COVID-19 pandemic …

… Python Competition Winners 21 Jun 2022 Read more QCRI Scientist Named ACM Distinguished Member 10 Feb 2022 Read more Qatar Computing Research Institute Achieves Milestone with its QARTA Street Map Routing Engine 18 Nov 2021 Read more …

QBRI Insights: Forerunners in the Vaccine Race Against SARS-CoV-2 31 Dec 2020 Home Since the start of the COVID-19 pandemic a year ago, there has been hope as well as skepticism about the rapid development of a vaccine against the SARS-CoV-2 virus, the strain of coronavirus that causes COVID-19 which has infected over 70 million people worldwide and caused 1.6 million deaths to date. The unprecedented efforts put into this cause are finally showing very positive signs, allowing us to end 2020 …

QBRI Insights: COVID-19 Treatment Recommendations 31 Jan 2021 Home Most people who contract COVID-19 are asymptomatic or have mild symptoms and can recover at home by getting enough rest, staying well hydrated, and taking medications that relieve fever, aches, and pains. However, the management of more severe forms of COVID-19 can be challenging. The early course of the infection, which is primarily driven by replication of the virus, is anticipated to be managed by antiviral therapies while …